"Significant milestone" in UK quality/safety reforms with medical professions white paper
This article was originally published in Clinica
Executive Summary
The UK's Department of Health has announced a "significant milestone" in its healthcare safety and quality programme, with the completion of the reforms of the UK's seven medical regulatory bodies. The reforms, which affect the regulation of professionals covered by the general medical, optical, osteopathic, nursing/midwifery, dental, chiropractic and health professions councils, are set out in the white paper Trust, Assurance and Safety, and feature the creation of fully-appointed "board-like" structures that "will enhance the ability of the regulators to act strategically".
You may also be interested in...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.